The benign prostatic hyperplasic devices market in the Middle East & Africa is expected to grow from US$ 91.28 million in 2022 to US$ 130.44 million by 2028; it is estimated to grow at a CAGR of 6.1% from 2022 to 2028.
Leading players in the benign prostatic hyperplasic devices market focus on expanding their customer reach across emerging markets in this region by expanding their distribution networks and augmenting manufacturing capabilities. In addition, high investments in life science and healthcare research in emerging countries play a crucial role in the upgrading of the latest technologies in developing countries. Crucial benign prostatic hyperplasic device manufacturers in the Middle East & Africa are expected to witness lucrative opportunities in the future owing to a large patient pool and high benign prostatic hyperplasia prevalence, increasing disposable income, improving healthcare infrastructure, and growing medical tourism in several countries.
With new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Middle East & Africa benign prostatic hyperplasic devices market at a substantial CAGR during the forecast period.
Based on procedure type, the Middle East & Africa benign prostatic hyperplasic devices market is segmented into transurethral microwave therapy, transurethral resection of the prostate, transurethral needle ablation of the prostate, laser surgery, urolift surgery, and others. The transurethral resection of the prostate segment held the largest market share in 2022, and it is also expected to register the highest CAGR in the market during the forecast period.
Based on end user, the Middle East & Africa benign prostatic hyperplasic devices market is segmented into hospitals, clinics, ambulatory surgical centers, and others. The hospital segment held the largest market share in 2022, while the clinics segment is expected to register the highest CAGR during the forecast period.
Based on country, the Middle East & Africa benign prostatic hyperplasic devices market is segmented into Saudi Arabia, South Africa, the UAE, and Rest of MEA. In 2022, Saudi Arabia held a larger market share. On the other side, and the UAE is expected to register a higher CAGR during the forecast period.
KARL STORZ SE & Co. KG; Olympus Corporation; Boston Scientific Corporation; Teleflex Incorporated; Butterfly; and ProArc are among the leading companies in the Middle East & Africa benign prostatic hyperplasic devices market.
Leading players in the benign prostatic hyperplasic devices market focus on expanding their customer reach across emerging markets in this region by expanding their distribution networks and augmenting manufacturing capabilities. In addition, high investments in life science and healthcare research in emerging countries play a crucial role in the upgrading of the latest technologies in developing countries. Crucial benign prostatic hyperplasic device manufacturers in the Middle East & Africa are expected to witness lucrative opportunities in the future owing to a large patient pool and high benign prostatic hyperplasia prevalence, increasing disposable income, improving healthcare infrastructure, and growing medical tourism in several countries.
With new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Middle East & Africa benign prostatic hyperplasic devices market at a substantial CAGR during the forecast period.
Middle East & Africa Benign Prostatic Hyperplasic Devices Market Segmentation
The Middle East & Africa benign prostatic hyperplasic devices market is segmented on the basis of product, procedure type, end user, and country. Based on product, the market is segmented into resectoscopes, urology lasers, radiofrequency ablation devices, prostatic stents, and implants. The resectoscopes segment is expected to hold the largest share of the market in 2022. On the other hand, the urology lasers segment is expected to register the highest CAGR during the forecast period.Based on procedure type, the Middle East & Africa benign prostatic hyperplasic devices market is segmented into transurethral microwave therapy, transurethral resection of the prostate, transurethral needle ablation of the prostate, laser surgery, urolift surgery, and others. The transurethral resection of the prostate segment held the largest market share in 2022, and it is also expected to register the highest CAGR in the market during the forecast period.
Based on end user, the Middle East & Africa benign prostatic hyperplasic devices market is segmented into hospitals, clinics, ambulatory surgical centers, and others. The hospital segment held the largest market share in 2022, while the clinics segment is expected to register the highest CAGR during the forecast period.
Based on country, the Middle East & Africa benign prostatic hyperplasic devices market is segmented into Saudi Arabia, South Africa, the UAE, and Rest of MEA. In 2022, Saudi Arabia held a larger market share. On the other side, and the UAE is expected to register a higher CAGR during the forecast period.
KARL STORZ SE & Co. KG; Olympus Corporation; Boston Scientific Corporation; Teleflex Incorporated; Butterfly; and ProArc are among the leading companies in the Middle East & Africa benign prostatic hyperplasic devices market.
Table of Contents
1. Introduction
3. Research Methodology
4. Middle East & Africa Benign Prostatic Hyperplasic Devices - Market Landscape
5. Middle East & Africa Benign Prostatic Hyperplasic Devices Market - Key Market Dynamics
6. Middle East & Africa Benign Prostatic Hyperplasic Devices Market Analysis
7. Middle East & Africa Benign Prostatic Hyperplasic Devices Market - by Product
8. Middle East & Africa Benign Prostatic Hyperplasic Devices Market - by Procedure Type
9. Middle East & Africa Benign Prostatic Hyperplasic Devices Market - by End User
10. Middle East & Africa Benign Prostatic Hyperplasic Devices Market - by Country Analysis
11. Middle East & Africa Benign Prostatic Hyperplasic Devices Market - Industry Landscape
12. Company Profiles
13. Appendix
List of Tables
List of Figures
Companies Mentioned
- KARL STORZ SE & Co. KG
- Olympus Corporation
- Boston Scientific Corporation
- Teleflex Incorporated
- Butterfly
- ProArc
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 126 |
Published | October 2022 |
Forecast Period | 2022 - 2028 |
Estimated Market Value ( USD | $ 91.28 Million |
Forecasted Market Value ( USD | $ 130.44 Million |
Compound Annual Growth Rate | 6.1% |
Regions Covered | Africa, Middle East |
No. of Companies Mentioned | 6 |